| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.7 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.7 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |